COMPANY PROFILE -Pharma Domain KSA (Kingdom of Saudi Arabia)
Business Sector :Pharmaceutical
Operating Geography :Kingdom of Saudi Arabia
About Pharma Domain KSA (Kingdom of Saudi Arabia) :
Saudi Arabia is one of the largest pharmaceutical markets in the Middle East, and its expansion over recent years can be attributed to a growing population, an increase in non-communicable diseases and strong state support for health services, with major government investment in new hospitals and clinics. The latest industry data reveals the Kingdom’s pharmaceutical market is expected to be valued at $10.74 billion (SR40.1 billion) by 2023
Pharma Domain KSA (Kingdom of Saudi Arabia) Revenue :
Competitive Analysis of Pharma Domain KSA (Kingdom of Saudi Arabia)
The SWOT analysis for Pharma Domain – KSA (Kingdom of Saudi Arabia) is presented below:
Strengths | Weaknesses |
1. Strong economic vision and strategic geographic location
2. Increasing multinational pharma investments
3. KSA - one of the largest pharmaceutical markets in the Middle East
| 1. Majority of pharmaceuticals manufactured overseas |
Opportunities | Threats |
1. National Transformation Program (NTP) to boost domestic pharma manufacturing
2. Government focus on spending on health and social development
3. Increasing preference for branded medications in KSA
4. Collaboration between domestic and international players
| 1. Weakening economic conditions
2. Accusations of committing glaring human rights abuses
|
On purchase the Pharma Domain KSA SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed SWOT Analysis of Pharma Domain KSA (Kingdom of Saudi Arabia)
Strength
This section is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
1. Weakening economic conditions: Low oil prices have caused a slowdown of the KSA economy which has affected consumer and business sentiment and has led to a lower GDP growth. The reduced oil production of 2019 in the kingdom is a result of an OPEC+ agreement that the country has signed. GDP growth has thus gone down to 1.7% year-on-year (y/y) in Q1 2019 as compared to 2.4% in 2018. This is further expected to fall to 0% in 2019 owing to poor global outlooks. The September attacks on several Saudi oil facilities also caused supply disruption and affected overall 2019 growth. Investments in the non-oil sectors like pharmaceuticals are also expected to get affected.
2. Accusations of committing glaring human rights abuses: Investors have become wary of entering the KSA market owing to several recent allegations regarding human rights abuses committed within the kingdom. Khashoggi's death, an anti-corruption purge that has supposedly led to the arbitrary arrests of hundreds of businessmen and royals and the detention and alleged torture of women's rights activists have all served to stain the kingdom’s image and make it a risky market for investment. A firm denial of all these allegations however has not been able to remove investor doubts. The international pharmaceutical involvement in the KSA market is likely to be affected by these events.
The PESTLE/PESTEL analysis of Pharma Domain – KSA (Kingdom of Saudi Arabia) is presented below:
Political | Economical |
1. Apprehensions on the stability of the current monarchy
2. Government spending and focus on pharma sector | 1. Falling oil prices |
Social | Technological |
1. Majority of population living in isolated areas, challenging consistent healthcare delivery
2. Rise in Preference for Branded Medications in Saudi Arabia
3. Rise in non-communicable diseases
| 1. Rise of telemedicine and e-health adoption
2. R&D investments in Saudi pharmaceuticals industry
|
Legal | Environmental |
1. Free-trade-zones to position Saudi Arabia as a pharmaceuticals manufacturing hotspot
2. Favourable regulations for locally manufactured products
3. Medication ingredient requirements in KSA | 1. Importance of sustainability in pharma sector |
On purchase the Pharma Domain KSA SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed Pestle Analysis of Pharma Domain KSA (Kingdom of Saudi Arabia)
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
This section is available only in the 'Complete Report' on purchase.
Technological
1. Rise of telemedicine and e-health adoption: The MOH of KSA has been charged by the government to develop a state of the art healthcare system which will be capable of providing quality healthcare to all citizens and especially to those in far flung areas. One such plan that has been developed and executed is the e-health system available at the Makkah city hospitals, King Abdullah Medical City (KAMC) and King Faisal Hospital (KFH). This system is being used to the maximum, proving the success of the system. The pharma sector is expected to see growth as a result of increased e-health utilization and application in other health sectors across KSA (13).
2. R&D investments in Saudi pharmaceuticals industry: The KSA pharma sector is undertaking significant R&D with the support of the KSA government in order to make domestic manufacturing of drugs better. The Saudi Vaccine and Biomanufacturing Centre is one such research facility under construction at the KAUST Research and Technology Park in Saudi Arabia. This facility will develop vaccines and biopharmaceutical products. The facility has the distinction of being the first such unit in the Middle East. The Research Products Development Company (RPDC), a subsidiary of Saudi Technology Development and Investment Company (TAQNIA), King Abdullah University of Science and Technology (KAUST), and SaudiVax are together developing this facility as per an agreement signed in March 2018. The Saudi Vaccine and Biomanufacturing Centre is expected to use GE Healthcare’s single-use biomanufacturing technology, FlexFactory which is able to deploy at quicker rates than traditional stainless-steel bioreactors. The unit will thus be able to process multiple products in lesser time. The technology also allows for modification according to the production requirements.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
On purchase the Pharma Domain KSA SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Pharma Domain KSA (Kingdom of Saudi Arabia):
-
Pharma Domain KSA (Kingdom of Saudi Arabia) Porter's Five Forces Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) VRIO Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) Value Chain Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) Covid-19 Impact Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) BCG Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) Segmentation, Targeting and Positioning (STP) Analysis |
|
-
Pharma Domain KSA (Kingdom of Saudi Arabia) Ansoff Matrix Analysis |
|
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Pharma Domain KSA (Kingdom of Saudi Arabia)
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Pharma Domain KSA (Kingdom of Saudi Arabia) SWOT & PESTLE Analysis Report
1. Saudi Arabia’s pharma market to reach $10.74 billion by 2022: http://saudigazette.com.sa/article/575657
2. Saudi Arabia’s Bold Ambition to Become a Regional Pharma Hub: https://pharmaboardroom.com/articles/saudi-arabias-bold-ambition-to-become-a-pharma-hub/
3. Aurobindo Pharma to build pharmaceutical factory in Saudi Arabia: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-to-build-pharmaceutical-factory-in-saudi-arabia/articleshow/50528783.cms?from=mdr
4. Sanofi Reinforces Its Local Presence In Saudi Arabia With The Inauguration Of Its Plant In KAEC: https://www.kaec.net/press_releases/sanofi-reinforces-its-local-presence-in-saudi-arabia-with-the-inauguration-of-its-plant-in-kaec/
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Pharma Domain KSA SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2025). Pharma Domain KSA SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/pharma-domain-ksa/ [Accessed 14 Feb, 2025].
In-text: (SWOT & PESTLE.com, 2025)
Copyrights and Disclaimer
Pharma Domain – KSA SWOT and PESTLE analysis has been conducted and reviewed by senior analysts from Barakaat Consulting.
Copyright of Pharma Domain – KSA SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.